Literature DB >> 10438387

Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera.

W T Jansen1, M A Breukels, H Snippe, L A Sanders, A F Verheul, G T Rijkers.   

Abstract

Fcgamma receptors show two genetically determined polymorphisms: the biallelic FcgammaRIIa-R131 and -H131 polymorphism and the NA1/NA2 FcgammaIIIb polymorphism. Using 10 pre- and postconjugate vaccination sera from adults, we analyzed in vitro phagocytic capacities of three different combinations of polymorphonuclear leukocyte FcgammaR allotypes: those homozygous for the H131 and NA1 allotype, those homozygous for the R131 and NA2 allotype, and those heterozygous for both receptors. For pre- and postvaccination sera, mean phagocytosis levels for the homozygous H131/NA1 allotype were 4 -fold higher than for the homozygous R131/NA2 allotype. There was a strong and significant correlation between IgG2 ELISA antibody titers and phagocytosis levels for the homozygous H131/NA1 Fcgamma receptor allotype and the heterozygous allotype but not for the homozygous R131/NA2 allotype. There was no relation between IgG1 ELISA titer and phagocytosis level. Apparently the IgG2 antibodies induced are functionally the most important. This may explain the large effect of Fcgamma receptor polymorphisms on in vitro phagocytosis of pneumococci mediated by conjugate antisera.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438387     DOI: 10.1086/314920

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Neutrophil responses to CRP are not dependent on polymorphism of human FcgammaRIIA (R131H).

Authors:  J A Rodríguez; K B Bodman-Smith; J G Raynes
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

2.  Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Authors:  W T Jansen; S Hogenboom; M J Thijssen; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe; A F Verheul
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.

Authors:  W T Jansen; M Väkeväinen-Anttila; H Käyhty; M Nahm; N Bakker; J Verhoef; H Snippe; A F Verheul
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.

Authors:  Y Sun; Y i Hwang; M H Nahm
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.

Authors:  David Tarragó; Julio Casal; Jesús Ruiz-Contreras; J Tomás Ramos; Pablo Rojo; Harm Snippe; Wouter T M Jansen
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

6.  Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients.

Authors:  Marie-Luise Arnold; Falko M Heinemann; Simon Oesterreich; Benjamin Wilde; Anja Gäckler; David Goldblatt; Bernd M Spriewald; Peter A Horn; Oliver Witzke; Monika Lindemann
Journal:  Vaccines (Basel)       Date:  2022-05-05

7.  Polymorphism of the Fcgamma receptor IIA and malaria morbidity.

Authors:  Erika Martins Braga; Kézia Katiani Gorza Scopel; Natália Tiemi Komatsu; Mônica da Silva-Nunes; Marcelo Urbano Ferreira
Journal:  J Mol Genet Med       Date:  2005-07-28

8.  Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.

Authors:  A Payeras; P Martinez; J Milà; M Riera; A Pareja; J Casal; N Matamoros
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

9.  Phenotypic and functional analysis of HL-60 cells used in opsonophagocytic-killing assay for Streptococcus pneumoniae.

Authors:  Kyung-Hyo Kim; Ju Young Seoh; Su Jin Cho
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

Review 10.  Human FcR polymorphism and disease.

Authors:  Xinrui Li; Andrew W Gibson; Robert P Kimberly
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.